Stay updated on Subcutaneous Atezolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.

Latest updates to the Subcutaneous Atezolizumab in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label at the bottom updated from v3.5.3 to v3.5.4, reflecting a new page build. This change affects page metadata and presentation but does not alter any trial data or content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page’s revision label changed from v3.5.2 to v3.5.3 in the footer, signaling a new release of the page’s record history. This is a minor update to the page’s versioning and does not alter the study details presented.SummaryDifference0.1%

- Check40 days agoChange DetectedThe history now shows a new revision entry (v3.5.2) and the previous revision (v3.5.0) has been removed from the version history.SummaryDifference0.1%

- Check68 days agoChange DetectedA new revision entry v3.5.0 was added to the Record History and the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check76 days agoChange DetectedThe study record history now includes a new revision v3.4.3 and removes revision v3.4.2.SummaryDifference0.1%

- Check104 days agoChange DetectedRevision: v3.4.2 was added to the history. The government funding notice banner previously shown on the page was removed.SummaryDifference0.8%

Stay in the know with updates to Subcutaneous Atezolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.